Patients should be advised to monitor blood glucose levels regularly, particularly during dose titration or if they notice unexplained sweating
Abstracts and reports from meetings were included only when they related directly to previously published work
After one year: Continued max dose: weight loss essentially fully maintained Stepped down to 5 mg: weight loss largely maintained, with an average regain of about 12 pounds Switched to placebo: large regain, with roughly 67% of patients eventually requiring rescue therapy That 12-pound tradeoff is the answer to the question patients ask most often: What does it actually cost me to step down
The most common ones include nausea, vomiting, diarrhea, and constipation
I think its very possible that the benefit will not last if the patients stop taking the drugs all together. But Schacht is unfazed by the idea that people who want to cut their alcohol use likely will need to continue taking GLP-1 medications
Typical self-induced restrictive diets are ineffective